What are the recommended dosing, monitoring requirements, and contraindications for propofol injection in adult patients undergoing induction and maintenance of general anesthesia?

Propofol Injection: Dosing, Monitoring, and Contraindications

For general anesthesia induction in healthy adults under 55 years, administer propofol 2-2.5 mg/kg IV titrated at approximately 40 mg every 10 seconds until loss of consciousness; for elderly, debilitated, or ASA-PS III-IV patients, reduce the dose to 1-1.5 mg/kg (approximately 20 mg every 10 seconds) to minimize cardiorespiratory depression. 1

Dosing Recommendations

Induction of General Anesthesia

Adult patients (ASA-PS I-II, <55 years):

• Dose: 2-2.5 mg/kg IV 1
• Administration: Titrate approximately 40 mg every 10 seconds until clinical signs show onset of anesthesia 1
• Onset: 30-45 seconds (one arm-brain circulation) 2

Elderly, debilitated, or ASA-PS III-IV patients:

• Dose: 1-1.5 mg/kg IV (approximately 20 mg every 10 seconds) 1
• Critical caveat: Rapid bolus administration must be avoided as it significantly increases risk of hypotension, apnea, airway obstruction, and oxygen desaturation 1
• Research confirms elderly patients require approximately 23% less propofol (1.7 vs 2.2 mg/kg) compared to younger patients 3

Pediatric patients (3-16 years, ASA-PS I-II):

• Dose: 2.5-3.5 mg/kg IV 1
• Younger children require higher doses than older pediatric patients 1

Maintenance of General Anesthesia

Continuous infusion (adults):

• Initial rate: 150-200 mcg/kg/min for first 10-15 minutes 1
• Maintenance rate: Decrease by 30-50% after initial period; target 50-100 mcg/kg/min to optimize recovery 1
• With nitrous oxide (60-70%): 100-200 mcg/kg/min provides adequate anesthesia 1

Pediatric maintenance:

• Initial rate: 200-300 mcg/kg/min immediately following induction 1
• After 30 minutes: Reduce to 125-150 mcg/kg/min 1
• Younger children typically require higher rates than older children 1

Intermittent bolus technique:

• 25-50 mg increments when vital signs indicate light anesthesia or surgical stimulation 1

Monitoring Requirements

Essential Monitoring (All Patients)

Before induction and continuously throughout:

• Pulse oximetry (SpO₂) with audible tones enabled 4
• Blood pressure (non-invasive or invasive) 2, 4
• Heart rate/ECG 2, 4
• Continuous waveform capnography from before induction until airway device removal and verbal response re-established 4

Additional monitoring:

• Quantitative neuromuscular monitoring when neuromuscular blocking drugs are used, from before blockade until train-of-four ratio >0.9 confirmed 4
• Processed EEG monitoring should be used when propofol is administered with neuromuscular blocking drugs to prevent awareness 4
• Supplemental oxygen should be provided to all patients 2

Specific Monitoring Considerations

Propofol infusion syndrome (PRIS) surveillance:

• Monitor for metabolic acidosis, hypertriglyceridemia, hypotension requiring increasing vasopressors, and arrhythmias 5
• PRIS typically occurs with doses >70 mcg/kg/min but can occur at lower doses 5
• Mortality from PRIS approaches 33%; early recognition and discontinuation are critical 5
• Incidence is approximately 1% with propofol infusions 5

Cardiovascular monitoring:

• Expect dose-dependent decreases in cardiac output, systemic vascular resistance, and arterial pressure 2
• Effects are more pronounced when combined with opioids or other CNS depressants 2, 5

Contraindications and Precautions

Absolute Contraindications

• Allergy to egg, soy, or sulfite (propofol contains 10% soybean oil, 1.2% purified egg phosphatide) 2
• Note: Propofol is NOT contraindicated in sulfonamide allergy 2

Relative Contraindications and High-Risk Situations

Cardiovascular instability:

• Baseline respiratory insufficiency or cardiovascular instability increases risk of cardiopulmonary complications 5
• In cardiac anesthesia, avoid rapid bolus; use slow rate of 20 mg every 10 seconds (0.5-1.5 mg/kg total) 1

Drug interactions:

• Opioids and barbiturates potentiate propofol's sedative effects; reduce propofol dose accordingly 2
• Morphine premedication (0.15 mg/kg) with nitrous oxide decreases required propofol maintenance rates 1

Common Adverse Effects

• Pain on injection: Occurs in up to 30% of patients 2
• Respiratory depression: Dose-dependent; responds rapidly to dose reduction 2
• Hypotension: Due to decreased preload and afterload 1
• Hypertriglyceridemia, acute pancreatitis, myoclonus 5

Critical Safety Points

Administration requirements:

• FDA label states propofol "should be administered only by persons trained in the administration of general anesthesia" 2
• However, with adequate training, physician-supervised nurse administration can be done safely and effectively 2, 6
• Worldwide experience exceeds 460,000 patients with no mortalities in gastroenterologist-directed administration 6

Pharmacokinetics:

• Duration of effect: 4-8 minutes after bolus 2
• Hepatic metabolism via glucuronide and sulfate conjugation 2
• Cirrhosis or renal failure do not significantly affect pharmacokinetics 2
• Long-term administration can saturate peripheral tissues causing prolonged emergence 5

Propofol has no analgesic properties—adequate analgesia must be provided separately 2, 5